Amicus Therapeutics
FOLD
FOLD
204 hedge funds and large institutions have $2.76B invested in Amicus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 78 increasing their positions, 60 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.64% more ownership
Funds ownership: 120.08% → 120.72% (+0.64%)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
22% less capital invested
Capital invested by funds: $3.53B → $2.76B (-$774M)
Holders
204
Holding in Top 10
9
Calls
$52.2M
Puts
$9.99M
Top Buyers
| 1 | +$34.6M | |
| 2 | +$19.6M | |
| 3 | +$18.5M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$16.5M |
| 5 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$15.3M |
Top Sellers
| 1 | -$64.2M | |
| 2 | -$57.1M | |
| 3 | -$41.4M | |
| 4 |
FM
Frazier Management
Seattle,
Washington
|
-$40.6M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$25.5M |